Iron Health Alliance is a global initiative dedicated to increasing awareness and sharing up-to-date information about iron toxicity with physicians and patients around the world.> Learn more
Ongoing and accurate assessment of body iron is essential for guiding therapy in chronic anemia patients who require repeated transfusions.> Learn more
Patients with chronic anemias should be informed about the pathophysiology of excess iron and the risks associated with iron overload.> Download Brochure
Patients with transfusion-dependent anemias, such as ß-thalassemia, are at risk of organ damage and increased morbidity or mortality due to accumulation of excess iron.> Learn more
Clinically relevant thalassemia falls into two major categories: transfusion-dependent thalassemia and non-transfusion-dependent thalassemia (NTDT). Patients with either form of the disease can develop serious iron overload.Learn more
Although relatively rare, myelodysplastic syndromes (MDS) are the most common malignant bone marrow disorders.Read more
Iron burden is a major determinant of morbidity and mortality in patients with sickle cell disease.Find out more
All fields are required.
You are now leaving the IronHealthalliance.com website by opening an external website independently operated and not managed by Novartis. Novartis assumes no responsibility for the site you are about to visit. If you do not wish to leave this site, click "Cancel." Otherwise, click "Continue".